This series on “Novel Therapies for Pancreas Cancer” is edited by Dr. Michael D. Chuong, De-partment of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, USA.
Michael Chuong, MD, FACRO
Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Mi-ami, FL, USA
Michael Chuong, MD, FACRO is a board-certified radiation oncologist at Miami Cancer Insti-tute, part of Baptist Health South Florida. Dr. Chuong is the Director of Proton Therapy, Direc-tor of MR-Guided Radiation Therapy, and Director of Radiation Oncology Clinical Re-search. He is the lead physician for the GI radiation oncology service. Dr. Chuong is also the Vice Chair of Education and Clinical Research and an associate professor in the Department of Radiation Oncology at the Florida International University Herbert Wertheim College of Medi-cine.
Dr. Chuong received his medical degree from the University of South Florida College of Medi-cine in Tampa, Florida and completed his radiation oncology residency training at the H. Lee Moffitt Cancer Center and Research Institute where he served as the Chief Resident.
Dr. Chuong holds leadership positions within several national and international organiza-tions. He is the Disease Site Chair of the Proton Collaborative Group, the Particle Therapy Co-operative Group GI Sub-committee co-chair, and a member of the NRG Oncology GI subcom-mittee. In addition to expertise in proton therapy, he is also an internationally recognized expert in the use of MR-guided radiation therapy. Dr. Chuong is frequently invited to speak about his expertise in treating cancer patients with both novel technologies.
Dr. Chuong has published over 70 peer-reviewed manuscripts and is the principal investigator for several national and international clinical trials exploring novel therapies for the manage-ment of GI cancers. He is an editor for several prominent journals including the International Journal of Radiation Oncology Biology Physics, Digestive Medicine Research, and Frontiers in Oncology.
Dr. Chuong has received numerous awards, including the American Society of Clinical Medi-cine Conquer Cancer Foundation Merit Award and the Moffitt Cancer Center Research Sympo-sium Clinical Research Symposium Clinical Research Award.
Series outline:
- Liquid biopsy for pancreas cancer
- Novel systemic therapies for pancreas cancer
- Optimal management of borderline resectable pancreas cancer
- Ablative radiation therapy for locally advanced pancreas cancer
- The role of radiation therapy for metastatic pancreas cancer
- Novel interventional oncology therapies for pancreas cancer
- Tumor Treating Fields for pancreas cancer
- Robotic surgery for pancreas cancer
- Radiomics of pancreas cancer
Disclosure:
The series “Novel Therapies for Pancreas Cancer”was commissioned by the editorial office, Digestive Medicine Research (DMR) without any sponsorship or funding. Michael D. Chuong served as the unpaid Guest Editor for the series.
